Cialis ® (tadalafil) tablets

2.5 mg, 5 mg, 10mg, 20 mg tablets

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Cialis® (tadalafil): Switching From an Alpha Blocker to Tadalafil for Benign Prostatic Hyperplasia

Patients on alpha blocker therapy for BPH should stop the alpha blocker at least one day before starting Cialis® (tadalafil) for once-daily use for the treatment of BPH.

Prescribing Information

The efficacy of the coadministration of an alpha blocker and tadalafil for the treatment of BPH has not been adequately studied.1

As the potential vasodilatory effects of combined use could result in lowered blood pressure, the combination of tadalafil and alpha blockers is not recommended for the treatment of BPH.1

Patients on alpha blocker therapy for BPH should discontinue their alpha blocker at least 1 day prior to starting tadalafil for once-daily use for the treatment of BPH.1

Enclosed Prescribing Information

CIALIS® (tadalafil) tablets, for oral use, Lilly

Reference

1. Cialis [package insert]. Indianapolis, IN: Eli Lilly and Company; 2018.

Glossary

BPH = benign prostatic hyperplasia

Date of Last Review: July 22, 2020


Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 7pm EST

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical